Developing a model to predict accrual to cancer clinical trials: Data from an NCI designated cancer center
Introduction: As cancer center funds are allocated toward several resources, clinical trial offices and the clinical trial infrastructure is constantly scrutinized. It has been shown that 20% of clinical trials fail to achieve their accrual goal and in an institutional level several trials are open...
Main Authors: | Praveena Iruku, Martin Goros, Jonathan Gelfond, Jenny Chang, Susan Padalecki, Ruben Mesa, Virginia G. Kaklamani |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-09-01
|
Series: | Contemporary Clinical Trials Communications |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2451865419300304 |
Similar Items
-
NCI–Clinical Trial Accrual in a Community Network Affiliated with a Designated Cancer Center
by: Daniel J. Kim, et al.
Published: (2020-06-01) -
The Impact of COVID-19 on Cancer Clinical Trials Conducted by NCI-Designated Comprehensive Cancer Centers
by: Diviya Gupta, et al.
Published: (2021-05-01) -
The University of Kansas Cancer Center (KUCC), an NCI designated comprehensive cancer center
by: Weijing Sun, et al.
Published: (2023-11-01) -
Investigating potential disparities in clinical trial eligibility and enrollment at an NCI‐designated comprehensive cancer center
by: Monica A. Patel, et al.
Published: (2023-06-01) -
Payer-Negotiated Prices for Breast Cancer Treatment at NCI-Designated Cancer Treatment Centers
by: Mathew, Angelin T., et al.
Published: (2022)